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Abstract: Schistosomiasis, a neglected tropical disease of medical and veterinary importance,
transmitted through specific freshwater snail intermediate hosts, is targeted for elimination in several
endemic regions in sub-Saharan Africa. Multi-disciplinary methods are required for both human and
environmental diagnostics to certify schistosomiasis elimination when eventually reached. Molecular
xenomonitoring protocols, a DNA-based detection method for screening disease vectors, have been
developed and trialed for parasites transmitted by hematophagous insects, such as filarial worms and
trypanosomes, yet few have been extensively trialed or proven reliable for the intermediate host snails
transmitting schistosomes. Here, previously published universal and Schistosoma-specific internal
transcribed spacer (ITS) rDNA primers were adapted into a triplex PCR primer assay that allowed
for simple, robust, and rapid detection of Schistosoma haematobium and Schistosoma bovis in Bulinus
snails. We showed this two-step protocol could sensitively detect DNA of a single larval schistosome
from experimentally infected snails and demonstrate its functionality for detecting S. haematobium
infections in wild-caught snails from Zanzibar. Such surveillance tools are a necessity for succeeding
in and certifying the 2030 control and elimination goals set by the World Health Organization.
Keywords: bovine; control; elimination; schistosomiasis; urogenital; surveillance; disease; parasite
Molecules 2020, 25, 4011; doi:10.3390/molecules25174011 www.mdpi.com/journal/molecules
Molecules 2020, 25, 4011 2 of 17
1. Introduction
Schistosomiasis is a disease affecting an estimated 229 million people worldwide caused by
infection with parasitic worms of the genus Schistosoma, leading to severe morbidity and mortality due
to the associated complications of worm presence [1]. Schistosoma spp. in Africa are transmitted through
specific freshwater snail intermediate hosts of the Bulinus and Biomphalaria genera [2]. Infections
occur when humans or animals come into contact with freshwater containing infectious larval stages
(cercariae) shed from the infected snails. Human schistosomiasis in Africa, where at least ~90%
of the people requiring treatment live [3], consists of two forms of the disease—urogenital and
intestinal schistosomiasis, caused predominantly by Schistosoma haematobium and Schistosoma mansoni,
respectively [1]. Bovine, ovine, and caprine schistosomiasis is also of significant veterinary and
economic importance across sub-Saharan Africa [4,5] and is caused by infection of cattle, sheep,
and goats with species closely related to S. haematobium (termed S. haematobium group species),
primarily Schistosoma bovis, Schistosoma curassoni, and Schistosoma mattheei. Overlapping geographical
distribution of multiple schistosome and intermediate snail host species strains complicates disease
transmission surveillance in (co)endemic zones [2,6,7].
The World Health Organization (WHO) aims for the elimination of human schistosomiasis
as a public health problem, defined as >1% of the population with heavy intensity infections
(≥50 schistosome eggs per 10 mL of urine, or ≥400 schistosome eggs per gram of feces [8]), in
all endemic countries by 2030 [9]. Despite great advances in schistosomiasis control mainly via
preventative chemotherapy (praziquantel), the lack of protection against rapid re-infection together
with prolific asexual replication of schistosomes within their intermediate snail host presents substantial
hurdles to achieving the targeted elimination of schistosomiasis. Very quickly, snails can become
infected by eggs emanating from untreated humans, leading to a rapid resurgence of transmission [10].
Therefore, adaptive treatment strategies that take into account the transmission dynamics of Schistosoma
spp. with their snail hosts are required to control and eliminate the disease [11].
To better understand the local transmission dynamics of different Schistosoma species, allowing
both human and bovine schistosomiasis to be monitored, a need exists for methodologies that detect
schistosome infections in the intermediate host snails. These tools for assessing Schistosoma transmission
could eventually be used during elimination programs to identify focal areas of persisting transmission
or certify elimination and/or transmission interruption [12–14]. Defining ongoing transmission in
snail populations through traditional methods of observing cercariae shed from snails is particularly
challenging in an elimination setting, such as the Zanzibar Archipelago, where few snails (0.5–2.3%)
are observed shedding cercariae [6,15]. Snails with non-patent (including pre-patent) infections are
missed using these approaches. Additionally, larval schistosomes are not easily identifiable to a species
level using morphological characteristics (although the relative position of sensory receptors is of some
value [16,17]).
Molecular xenomonitoring is a DNA-based method that has been developed to monitor the
transmission of several vector-borne diseases, including trypanosomiasis [18,19], filariasis and
malaria [20], helminthiases [21], and fascioliasis [22], including to some extent schistosomiasis [23–29].
Screening snails provides evidence on the extent of environmental contamination (i.e., schistosome
miracidia penetrating snails), as well as environmental infection risk (i.e., schistosome sporocysts and
cercariae developing inside the (pre-patent) snails, eventually emerging from the (patent) snail. Most
of the available snail-schistosome xenomonitoring assays do not include internal controls [23,28,30], an
important feature in any diagnostic tool that helps prevent false-negative results [27]. Many assays
will assume that a negative result means non-infection, not necessarily reaction failure.
In the current study, we adapted available universal [31] and Schistosoma-specific [27] internal
transcribed spacer (ITS) rDNA primers to design a three primer multiplex assay and tested this as a
simple, robust, and rapid xenomonitoring PCR assay to enable the large-scale screening of Bulinus
snails for Schistosoma infections (S. haematobium and S. bovis). We used a conventional PCR-based
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approach focused on simplicity, ease of data interpretation, sensitivity, and specificity, with a primary
aim to provide a xenomonitoring tool for monitoring S. haematobium transmission in endemic settings.
2. Results
2.1. In Silico and In Vitro Primer Evaluation
Bulinus globosus and Bulinus nasutus rDNA sequence data showed conserved primer binding sites
for the universal primers ETTS2 and ETTS1 [31] at the 3′ end of the 18S and 5′ end of the 28S, the
flanking regions of the ITS, respectively. ETTS1 gave a 100% match, and the ETTS2 primer showed just
a single base pair mismatch. The resulting snail amplicon size predicted from these alignments was
between 1232 and 1263 bp and served as an internal snail control during PCR amplification.
Alignments of the Schistosoma-specific ITS primers (ITS2_Schisto_F and ITS2_Schisto_R [27])
showed 100% and 90% (2 mismatches) homology to S. haematobium and S. bovis, respectively, with no
cross-reactivity to the Bulinus reference rDNA data. When paired with their opposing universal
primers (ITS2_Schisto_F + ETTS1 or ITS2_Schisto_R + ETTS2), the amplicon sizes of 538 and 835
bp were predicted, respectively, for Schistosoma. With the addition of the other universal primer to
each combination (ETTS2 and ETTS1, respectively), the three-primer multiplex ITS xenomonitoring
(MIX) reactions were predicted to be able to produce distinct amplicon profiles for non-infected snails
(a single snail amplicon) and snails infected with Schistosoma spp. (three-band profile). This was
confirmed by in vitro testing of the primer combinations (Figure 1).
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Figure 1. Singleplex (A); ETTS2 + ETTS1) and multiplex (B); multiplex ETTS2 + ETTS1 + ITS2_Schisto_F,
(C); ETTS2 + ETTS1 + ITS2_Schisto_R) PCRs on laboratory-bred Bulinus wrighti (B.w.) and
Schistosoma haematobium (S.h.) gDNA separately (1; B.w., 2; S.h.) and combined (3; B.w. + S.h.).
When B.w. and S.h. DNA was combined (A3, B3, C3), two amplicons were produced by the ETTS1 +
ETTS2 primers, a larger snail amplicon (Sn) (~1200 bp) and a smaller Schistosoma amplicon (T) (~1000),
with the additional Schistosoma-specific prim rs producing either a 538 bp (B3; ITS2_Schisto_F) or 835
bp (C3; ITS2_Schisto_R) amplicon (S). A larger amplicon (A) (~1400–1600 bp) was also obs rved to be
amplified in so e reactions, and this was thought to be a PCR artifact or additional primer targets in
the Schistosoma gDNA. L1 = HyperLadder I (Bioline, London, UK). -ve = negative, no template control.
ITS = internal transcribed spacer.
To maximize amplification efficiency/sensitivity and to provide good amplicon size differentiation,
the multiplex PCR incorporating the internal ITS2_Schisto_F (Figure 1B) was selected for further
development and testing. This primer combination was also selected as it targeted the ITS2 region for
Schistosoma containing four species-specific SNPs, enabling species identification (Table 1).
The MIX assay proved robust at varying annealing temperatures (55 ◦C, 60 ◦C Figure 2A, 58 ◦C
Figure 2B), with 58 ◦C proving to be the most efficient, aximizing specificity without decr asing
sensitivity. Each of the three amplicons was extracted from the gel and sequenc d, confirming the
band identity and specificity of the primers to their target gDNA amplicon. These three bands have
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been described as the snail (Sn) (1232–1263 bp), trematode (T) (~1000 bp), and Schistosoma (S) (538 bp)
bands going forward. The secondary Schistosoma ITS xenomonitoring (SIX) PCR, solely targeting the
Schistosoma amplicon, proved robust, enabling single amplicon generation and sequencing (Figure 3).
This provided a two-step PCR methodology with the MIX PCR for the initial high-throughput screening
of the samples and the secondary SIX PCR to target specific samples for further infection clarification
by Schistosoma species identification through DNA sequencing.
Table 1. Schistosoma species-specific SNP positions (including base position) in the internal transcribed
spacer (ITS)2 region.
Schistosoma Species
ITS 2 Schistosome Species-Specific SNP Positions (bp)
SNP1 (90) SNP2 (145) SNP3 (195) SNP4 (265)
S. haematobium S. h (G) S. h (C) S. h (G) S. h (C)
S. bovis S. b (A) S. b (T) S. b (A) S. b (T)
Molecules 2020, 25, x FOR PEER REVIEW 4 of 18 
 
been described as the snail (Sn) (1232–1263 bp), trematode (T) (~1000 bp), and Sc istosoma (S) (538 bp) 
bands going forward. The secondary Schist soma ITS xenomonitoring (SIX) PCR, solely targeti g the 
Schistosoma amplicon, proved robust, enabling single amplicon generation and sequencing (Figure 
3). This provided a two-step PCR methodology with the MIX PCR for the initial high-throughput 
screening of the samples and the secondary SIX PCR to target specific samples for further infection 
clarification by Schistosoma species identification through DNA sequencing. 
Table 1. Schistosoma species-specific SNP positions (including base position) in the internal 
transcribed spacer (ITS)2 region. 
Schistosoma Species 
ITS 2 Schistosome Species-Specific SNP Positions (bp) 
SNP1 (90) SNP2 (145) SNP3 (195) SNP4 (265) 
S. haematobium S. h (G) S. h (C) S. h (G) S. h (C) 
S. bovis S. b (A) S. b (T) S. b (A) S. b (T) 
 
Figure 2. Multiplex ITS xenomonitoring assay trial at 55 °C (A) and 60 °C (B). Includes gDNA of 
Bulinus wrighti of both BioSprint (Lane 1 and 5) and DNeasy extractions (Lane 2 and 6) and gDNA of 
Schistosoma haematobium (Lane 3 and 5) and S. bovis (Lane 4 and 6). Combinations of B. wrighti and S. 
haematobium (Lane 5) or S. bovis (Lane 6) gDNA shown. Sn = snail amplicon, T = trematode amplicon, 
S = Schistosoma amplicon, and A = non-specific amplicon or artifact. L1 = HyperLadder I. L2 = 
HyperLadder IV (Bioline, London, UK). -ve = negative, no template control. 
 
Figure 3. Gel showing the secondary singleplex ITS xenomonitoring (SIX) PCR for 1) Schistosoma 
haematobium gDNA; 2) S. bovis gDNA; 3) S. haematobium + B. wrighti gDNA; 4) S. bovis + B. wrighti 
gDNA. -ve = non-template negative control. L1 = HyperLadder I (Bioline, London, UK). 
2.2. Analytical Sensitivity 
Figure 2. Multiplex ITS xenomonitoring assay trial at 55 ◦C (A) and 60 ◦C (B). Includes gDNA of
Bulinus wrighti of both BioSprint (Lane 1 and 5) and DNeasy extractions (Lane 2 and 6) and gDNA
of Schistosoma haematobium (Lane 3 and 5) and S. bovis (Lane 4 and 6). Combinations of B. wrighti
and S. haematobiu (Lane 5) or S. bovis (Lan 6) gDNA sh wn. Sn = snail amplicon, T = trematode
amplicon, S = Schistosoma amplic , and A on-specific ampli n r artifact. L1 = HyperLadder I.
L2 = HyperLadder IV (Bioline, London, UK). -ve = negative, no template control.
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2.2. Analytical Sensitivity 
Figure 3. Gel showing the secondary singleplex ITS xenomonitoring (SIX) PCR for 1)
Schistosoma haematobium gDNA; 2) S. bovis gDNA; 3) S. haematobium + B. wrighti gDNA; 4) S. bovis +
B. wrighti gDNA. -ve = non-template negative control. L1 = HyperLadder I (Bioline, London, UK).
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2.2. Analytical Sensitivity
The assay proved highly sensitive with a limit-of-detection (LoD) of 0.02 ng and 0.002 ng of gDNA
for S. bovis and S. haematobium, respectively (Figure 4). Sensitivity appeared higher for S. haematobium
(Figure 4), but in both the cases, the assay’s sensitivity was above that necessary to detect gDNA from
a single miracidium, which ranges from 1.6–3.65 ng/µL [32]. At lower Schistosoma DNA concentrations,
the 1005 bp trematode band (T) lost sensitivity compared with the smaller Schistosoma-specific band.
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left for 11 weeks, did not reach patency but were also confirmed to be penetrat d by S. h ematobium
miracidia (Figure 5: Lanes 20 and 21). The secondary SIX PCR was performed on all 13 non-patent
infected sna ls, and the s ngle amplicons were sequenced and confirmed as S. haematobium. Out of
all the snails infected that survived until the end of the experiment (11 we ks), 15% ( ine out of 62)
reached patency, of whi two had been infe ted with two miracidia, and seven w th seven miracidia.
One of these s mples, infected with two mira idia, was analyzed using the MIX PCR, giving the
expected triple banding pattern (snail, trematode, nd Schis soma) (Figure 5: L ne 24). All thre
amplicons from this sample (Figure 5: Lane 24) w re gel extracted and sequen ed, confirming their
identity. Interestingly, in all the non-patent infections, the large trematode amplicons (ETTS2-ETTS2)
did not amplify (Figure 5) ue t the low level of Schistos ma DNA pr sent in the snails that did no
reach patency.
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Figure 5. Experimental infections of Bulinus truncatus with Schistosoma haematobium (1–24),
field-collected B. globosus infected with Euclinostomum sp. (Euc.) and field-collected B. nasutus
shedding Echinostoma sp. cercariae (Ech.). The S. haematobium DNA amplicon was present (+ve) in 13
of the 23 non-patent snails (11 at 24 h post-exposure, and two at 11 weeks post-exposure), highlighted
by the arrow. Lane 24 = B. truncatus sample that was shedding S. haematobium cercariae 11 weeks
after exposure. The positive control (+ve) is a mix of B. wrighti nd S. haematobium control gDNA. L1:
HyperLadder I, L2: Hyp der IV (Bioline, L don, UK).
2.4. Specificity Testing
The B. globosus with patent S. haematobium (n = 2) and S. bovis (n = 5) infections showed the
expected triple banding pattern (snail, trematode, and Schistosoma amplicons, results not shown),
and following gel extraction and sequencing the data matched those from the cercariae collected from
these samples (GenBank Accessions: MH014047 and MH014044, see [6]).
When the MIX PCR was test d on snails o fir ed to be infected with oth r commonly found
trematode species (B. globosus infecte with Euclinosto um sp., and the B. nasutus infected with
Echinostoma sp. (Figure 5: Lanes Euc. and Ech.)), no Schistosoma amplicon was observed. However,
there was strong amplification of the trematode band together with the snail band. These trematode
amplicons were gel extracted, sequenced, and the infections were confirmed as Euclinostomum sp. and
Echinostoma sp., matching data from the cercariae originally collected from each snail.
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2.5. Testing on Field Samples
From the 94 field-collected B. globosus, 33 were shown to be infected with Schistosoma spp. with
amplification of the Schistosoma-specific band (Figure 6). Among them, eight also presented the
trematode band. The internal snail control was amplified in all samples apart from one. The one that
failed was predicted to be due to poor sample preservation, gDNA extraction, or PCR error, and so was
disregarded (Figure 6). Of all the samples that gave the Schistosoma-specific band, the secondary SIX
PCR (ITS2_Schisto_F + ETTS2) was conducted, and all amplicons were Sanger sequenced. Two failed to
amplify, but the remaining 31 produced the Schistosoma amplicon that all sequenced as S. haematobium.
One sample also gave the trematode band without the Schistosoma band, indicating a non-Schistosoma
trematode infection.
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Figure 6. Gel images for the multiplex ITS xenomonitoring (MIX) PCR amplicons for 94 non-patent
Bulinus globosus collected from Wambaa, Pemba, United Republic of Tanzania. The text under each
amplicon denotes the outcome of the Schistosoma sp. targeted sequencing where relevant (i.e., presence
of 538 bp amplicon), which resulted in either S. aematobium (S.h.) or equenci g failure (F). The presence
of a trematode band without the presence of the Schistosoma band indicated a non-Schistosoma trematode
infection (Tr.). Other non-specific bands, in this case, larger bands (NA), were also observed in these
snail populations, which did not amplify with the secondary SIX PCR. x = sample failure with no
control amplicon. Arrows highlight the presence of the ~1000 bp trematode band when present (n = 8).
B. globosus with a patent S. haematobium infection (Cham10.1 see [6]) was run as a positive control (+ve)
and also represented the amplicon profile obtained for the seven patent B. globosus snails (five and
two with S. bovis and S. haematobium infections, respectively (see Section 2.4). -ve = the non-template
negative control. L1—HyperLadder IV (Bioline, London, UK).
2.6. Schistosoma spp. cox1 RD-PCR
Despite trying different annealing temperatures and gDNA template amounts used, the cox1
RD-PCR, developed by Webster et al. (2010) [33], tested on the patent S. haematobium and S. bovis-infected
B. globosus, only generated the species-specific amplicon for S. bovis-infected snails. PCRs for the
S. haematobium-infected snails repeatedly failed to produce a clear amplicon. The cox1 amplicons
produced for the S. bovis-infected snails were sequenced, and the data matched that obtained from the
cercariae collected and analyzed from the snails (see [6]).
3. Discussion
Pre-patent and non-patent snail screening methods for schistosomes, such as molecular
xenomonitoring, offer a higher sensitivity over traditional snail shedding methods that can only
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detect patent infections by the observation of schistosome cercariae. Molecular xenomonitoring
better helps to assess the impact of schistosomiasis control interventions in local communities,
particularly where local elimination is being achieved, and certification of the absence of transmission
is required at specific foci. However, the diversity of schistosomes circulating in co-endemic areas
means that species-specific methods are needed to prevent false-positive data due to non-target
species cross-reactivity.
Here, we describe the development and application of a molecular xenomonitoring pipeline for
the detection and differentiation of S. haematobium and S. bovis patent and non-patent infections in
Bulinus freshwater snails, using three previously developed primers [27,31]. The MIX assay screens
for Schistosoma and other trematode species, while also incorporating an internal control, in this case,
gastropod DNA, an important feature for any molecular diagnostic assay. The MIX PCR generates
clearly identifiable amplicons, of different sizes, for each target (snail, trematode, Schistosoma), which
are visible by simple agarose gel electrophoresis. However, the trematode target lacks sensitivity at
low DNA concentrations, probably due to its large size and PCR biases for small amplicons at reduced
gDNA concentrations. Interestingly, a PCR artifact (~1400–1600 bp) is also observed when using the
MIX assay in the presence of Schistosoma DNA, suggesting that the primers may have a secondary
binding site. However, this artifact is clearly identifiable from the main target amplicons and does not
mislead the interpretation of the results.
3.1. The Sensitivity of MIX PCR Assay
Our in silico and in vitro testing of the MIX assay shows that the presence of S. haematobium and
S. bovis DNA can be routinely detected at low concentrations and also is able to identify non-patent
Schistosoma infections in snails where the level of DNA varies depending on the development of the
infection. The LoD for Schistosoma DNA is ≤0.02 ng/µL, which is 80-fold lower than the minimum
amount of gDNA usually observed from a single miracidium [32]. This is also demonstrated by
the assay’s ability to detect pre-patent snail infections 24 h after exposure to a single miracidium.
This provides sufficient sensitivity for the LoD needed to detect any stage of snail infection, from
initial miracidia penetration of a single miracidium to full patency, in natural settings. The fact that
not all the snails tested from the experimental snail infections give positive results is corroborative
with observations that, even in the experimental systems, many snails avoid penetration or destroy the
miracidia rapidly upon invasion. The MIX and SIX methodologies also prove robust when used to
screen ‘wild-caught’ snails from Pemba, with uninfected, pre-patent S. haematobium-infected snails,
and non-Schistosoma trematode infections are clearly identified.
3.2. Benefits of an Updated Molecular Xenomonitoring Protocol for Schistosomiasis Surveillance
The molecular xenomonitoring protocol requires few consumables and no cold chain, and results
can be interpreted using basic molecular laboratory equipment (thermocycler and gel electrophoresis),
making the molecular assay accessible in lower resource settings, such as schistosomiasis endemic
regions. The molecular xenomonitoring approach described here, therefore, provides a useful tool
for monitoring schistosomiasis transmission, as has been outlined as a necessary method for leading
toward the WHO 2030 goals for schistosomiasis control and elimination [9].
Molecular xenomonitoring surveillance techniques are often associated with parasites transmitted
by hematophagous insects, such as lymphatic filaria in mosquito vectors [20,34–36] and trypanosomes
in tsetse flies [18,19]. However, several assays have been developed for detecting trematode
species in freshwater snails, including Fasciola spp. [22,37–44], other wildlife trematode species [45],
and medically important schistosome species—S. japonicum [46,47], S. mansoni [24,27,28,48–54],
and S. haematobium [23,26,27,30,52,54,55]. The first developed assay for the molecular detection of
S. haematobium DNA in Bulinus employs the highly repetitive Dra1 target, and this has been the marker
of choice for studies investigating S. haematobium infections in snails due to its high sensitivity [55].
However, the specificity of the Dra1 and the interpretation of results can be problematic due to the
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frequent false-positive and -negative results, lack of internal control, and difficulties in interpreting
the amplicon patterns. Furthermore, this marker does not allow for species identification. Kane et al.
(2013) [54] employed the use of another repetitive marker, intergenic spacer (IGS), for the detection
of snail infections, and a post-amplification restriction digest allowed for the downstream species
identification of S. haematobium and S. bovis. However, the method lacks internal controls. In addition,
many of these assays use quantitative-PCR (qPCR), rather than conventional PCR/gel electrophoresis.
Although able to quantify levels of DNA within a sample, qPCR is more arduous to carry out and lesser
suited for use in endemic settings. However, recent technological advances in sample preparation
and DNA extraction methods have demonstrated robust field setting methodologies to conduct qPCR
analysis capable of detecting avian trematodes and host species in Canadian lakes [56–58], which could
potentially be modified to suit the detection of human and bovine schistosomes in sub-Saharan Africa,
although cost and throughput would need to be considered.
A recent assay designed by Schols et al. (2019) [27] is a six primer multiplex PCR, which
incorporates an internal snail control and offers a xenomonitoring tool for S. haematobium group species
that are transmitted by Bulinus snail hosts. Our study simplifies the multiplex process, reducing the
primer numbers and mitigating against PCR competition and some of the biases that may occur with
multiple primer combinations. It also allows for greater amplicon size differentiation (as amplicon sizes
can be more easily distinguished based on size), making results more interpretable. The ITS rDNA is a
favorable target within the repeat ribosomal operon of Bulinus and Schistosoma spp., easily detected
within small quantities of DNA due to the high copy number of rRNA clusters within eukaryote
genomes. Another key feature of the target relates to specificity. The ITS regions of Schistosoma and
Bulinus spp. can be routinely amplified using conventional PCR, thanks to its small size (~1000 bp)
and highly conserved flanking regions (5′18S and 3′28S), enabling the use of universal primers (ETTS1
+ 2) for multiple species [31]. However, interspecies heterogeneity and, to a lesser extent, intraspecies
heterogeneity (Pennance et al., unpublished observations) of the ITS regions allow for differentiation
between species, such as those of the S. haematobium group [7,33]. The internal Schistosoma-specific
primer is situated in a conserved ITS region within the Schistosoma genus, with 100% conservation
between several African species, suggesting that it could be utilized for several Schistosoma-snail
transmission systems.
3.3. Limitations of Molecular Xenomonitoring Approaches for Schistosomiasis Surveillance
From our study, we have identified two limiting factors for the practical use of this method. First,
the laborious nature of testing each individual snail adds time and cost. Further sensitivity testing
should be performed to support the development of pooling strategies. This would help to determine
whether infections are still detected when the Schistosoma DNA is diluted in the presence of much higher
concentrations of snail DNA, which may inhibit the reaction. Pooling strategies have been successful
for arthropod xenomonitoring protocols [18] and would allow for higher throughput of samples
required for screening large populations of snails, such as those encountered for schistosomiasis.
Second, a limitation does come with the need for the secondary screening (SIX PCR) of the
Schistosoma amplicon, via sequencing, to confirm species. Despite best efforts, rapid species diagnostics,
such as the rapid diagnostic cox1 RD-PCR developed by Webster et al. (2010) [33] to determine adult
worm and larval stage species identity, is not robust when snail DNA is present, particularly for
S. haematobium infections. The cox1 RD-PCR was suggested as a secondary screening method by Schols
et al. (2019) [27], but it was only theoretically examined as part of that study. Clearly, further ‘wet lab’
testing on infected snails is needed. In regions where Schistosoma hybridization occurs, mitochondrial
DNA analysis would be necessary since both nuclear and mitochondrial DNA are required for hybrid
identification [33]. Unfortunately, as with most diagnostics, there is a balance between sensitivity
and specificity, with sensitivity increasing and specificity decreasing, usually due to the nature of the
biomedical targets. Here, rapid screening with high sensitivity is a priority due to the low levels of
infections in our study sites, with secondary species-specific screening only required on a subset of
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samples that are identified as infected. Moreover, Zanzibar previously thought to be a S. haematobium
transmission only zone, although, with the recent report of S. bovis transmission [6], the additional
species-specific screening is warranted. However, the need for the secondary screening step for
Schistosoma species identification does need further exploration, such as trialing more direct methods
that negate DNA sequencing, for example, amplicon enzyme restriction digestion demonstrated in
Kane et al. (2013) [54]. However, it is also important to gather detailed information, as is obtained
through DNA sequencing and analysis [6,7]. It is likely that xenomonitoring methods may need to be
adapted to optimize focal surveillance strategies to specific endemic zones due to geographical genetic
differences of the target organisms and potential unidentified species.
4. Materials and Methods
4.1. Primer Selection and In Silico Evaluation
The universal primer pair, ETTS2 and ETTS1 (Table 2 and Figure 7), was selected for the
development of the internal control for the assay. They anneal to conserved flanking regions either
side of the ITS(1 + 2) rDNA region of Schistosoma spp., amplifying the full ITS rDNA regions, resulting
in an amplicon of ~1005 bp [6,7,31,33]. These primers have also been demonstrated to amplify the full
ITS rDNA region of other organisms, including intermediate gastropod hosts. Primer’s cross-reactivity
with the target Bulinus snail hosts was further confirmed through alignments of the ETTS2 and ETTS1
primers with B. globosus and B. nasutus rDNA regions, available from ongoing projects (Briscoe et al.
unpublished data, Pennance et al. unpublished data).
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Figure 7. Primer annealing positions flanking and internal to the ITS1 + 2 rDNA targets. Primer
positions were mapped to Schistosoma haematobium and S. bovis ITS1 + 2 reference data [59] and to a
Bulinus globosus and B. nasutus DNA reference (Pennance et al., unpublished data). For Schistosoma
DNA, the primer combinations produced two fragments; 1) ETTS2–ETTS1 (1005 bp) and either 2)
ITS2_Schisto_F-ETTS1 (538 bp) or 3) ITS2_Schisto_R-ETTS2 (835 bp). For Bulinus DNA, the primer
combinations produced one fragment, ranging in size between 1232 and 1263 due to interspecies
variation. For Schistosoma species identification, four SNPs were present at bp positions 90, 145, 195,
and 265 in the ITS2 rDNA region, allowing differentiation of S. haematobium and S. bovis following
ITS2 sequencing.
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To develop the Schistosoma-specific target, two Schistosoma specific primers (ITS2_Schisto_F and
ITS2_Schisto_R), published by Schols et al. (2019) [27], were selected, targeting the internal ITS1 and
ITS2 rDNA regions of Schistosoma (Figure 7). These were further tested in silico for specificity by
stringently aligning them with rDNA sequence data (Briscoe et al., unpublished data; Pennance et al.,
unpublished data) of a single B. globosus and B. nasutus from both Unguja and Pemba island (Zanzibar,
United Republic of Tanzania) and those previously published for Schistosoma spp. [59,60].
All alignments were performed using Sequencher v5.4.6 (Gene Codes Corporation, Michigan,
USA), and the primer positions were used to predict the specific amplicon sizes that would result,
following amplification of snail and schistosome DNA using the different primer combinations of
ETTS1, ETTS2, ITS2_Schisto_F, and ITS2_Schisto_R.
Table 2. Details of the primers selected for the development of the xenomonitoring assay. Universal
(U) and specific (S) denote whether the primers universally target both Schistosoma and snail or just
specifically target Schistosoma DNA.
Primer (Direction) Primer Sequence (5′-3′) Primer Position State Reference
ETTS1 (Reverse) TGCTTAAGTTCAGCGGG 28S 5′ end (ITS2 3′ flanking region) U Kane et al. (1994) [31]
ETTS2 (Forward) TAACAAGGTTTCCGTAGGTGA 18S 3′ region (ITS1 5′ flanking region) U Kane et al. (1994) [31]
ITS2_Schisto_F (Forward) GGAAACCAATGTATGGGATTATTG ITS1 3′ end (5.8S 5′ flanking region) S Schols et al. (2019) [27]
ITS2_Schisto_R (Reverse) ATTAAGCCACGACTCGAGCA ITS2 (middle) S Schols et al. (2019) [27]
4.2. Bulinus and Schistosoma Genomic DNA Extractions
Whole soft tissue from Bulinus samples (as detailed below) available through the Schistosomiasis
Collection at the Natural History Museum (SCAN) [61] and other ongoing projects, including laboratory
and field samples, infected/non-infected and patent/non-patent, were used for the assay development
and validation. Genomic DNA (gDNA) from all Bulinus samples was extracted using a modified tissue
lysis protocol [6]. Two kits were then used to extract total gDNA from the lysed snail tissue—the
BioSprint 96 DNA Blood Kit (Qiagen, Manchester, UK) for high-throughput multiple sample processing,
and the DNeasy Blood & Tissue Kit (Qiagen, Manchester, UK) for single sample processing. Protocols
were carried out according to the manufacturer’s instructions.
Positive control Schistosoma gDNA was obtained from adult worms; S. haematobium (single female
worm from Zanzibar) and S. bovis (single male worm from Senegal) were available from SCAN.
DNA was extracted following the DNeasy Blood & Tissue Kit protocol according to manufacturer’s
instructions (Qiagen, Manchester, UK) [60].
4.3. PCR Conditions, Amplicon Visualization, and Sequencing
All PCR amplifications were performed in 25 µL reactions using illustraTM PuReTaq
Ready-To-GoTM PCR Beads (GE Healthcare, UK) with 1 µL of each primer, in their different
combinations, as stated in each section, at a concentration of 10 µM. gDNA templates (Schistosoma
and/or Bulinus sp.) were added at different volumes and concentrations, as detailed below. The PCR
cycling conditions for all multiplex and singleplex reactions were as follows: initial denaturation 5 min
at 95 ◦C, followed by 40 cycles of 30 s at 95 ◦C, 30 s at 58 ◦C (unless stated otherwise), 90 s at 72 ◦C, and
a final extension of 10 min at 72 ◦C. The visualization of all PCR products was performed by running
7.5 µL of each PCR product, mixed with 2 µL of Bioline 5x DNA Loading Buffer Blue (London, UK)
and GelRed for visualization under UV light, on a 2% agarose gel for 90 min at 90 V. HyperLadder
I and HyperLadder IV were run alongside the PCR amplicons to assess fragment sizes. Gels were
visualized using a GBOX-Chemi-XRQ gel documentation system (Syngene, Cambridge, UK).
To validate amplification specificity, selected PCR amplicons from multiplex PCRs, where multiple
amplicons were present, were cut from agarose gels and sequenced following purification using
the QiaQuick Gel Purification Kit (Qiagen, Manchester, UK) following manufacturer’s instructions.
For singleplex reactions, resulting in a single amplicon, PCR products were purified using the QiaQuick
PCR Purification Kit (Qiagen, Manchester, UK) following the manufacturer’s instructions. The
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amplicons were sequenced in both directions using dilutions of the PCR primers. The sequence data
were manually edited using Sequencher v5.4.6 (Gene Codes Corporation, Michigan, USA), and the
amplicon identification was confirmed by comparison to Schistosoma reference data [59] and by BLAST
analysis (BLAST: Basic Local Alignment Search Tool, NCBI).
4.4. In Vitro Primer Testing and Assay Validation
All gDNA extractions from laboratory-bred Bulinus wrighti (not exposed to any trematodes
and, therefore, negative for infection) and from the S. haematobium and S. bovis adult worms were
quantified using a Qubit® Fluorometer using the dsDNA Broad Range (BR) Assay Kit (Molecular
Probes, Life Technologies). The gDNA extracts from the single adult S. haematobium and S. bovis
worms were normalized, using nuclease-free water, to 2 ng/µL (± 0.05 ng/µL). The gDNA extract
of a B. wrighti snail control was recorded and kept at 31.3 ng/µL. Template gDNA (1 µL) was used
in each PCR separately or combined and used to test the different primer combinations (shown in
Figure 1). The primers were tested as singleplex PCRs for the internal control (ETTS2 + ETTS1),
targeting both snail and Schistosoma gDNA, and then as multiplex PCR’s incorporating each of the
internal Schistosoma-specific primers (ETTS2 + ETTS1 + ITS2_Schisto_F or ITS2_Schisto_R). All test
PCRs were initially performed at an annealing temperature of 55 ◦C.
The multiplex primer combination ETTS2 + ITS2_Schisto_F + ETTS1 was selected and taken
forward for further development and validation. This is referred to as the multiplex ITS xenomonitoring
(MIX) PCR. The MIX PCR was further tested at annealing temperatures of 58 ◦C and 60 ◦C
to enhance assay specificity, with 58 ◦C taken forward for further experiments. Additionally,
a secondary Schistosoma ITS xenomonitoring (SIX) PCR, incorporating just the Schistosoma-specific
primer (ITS2_Schisto_F) and its universal reverse primer (ETTS1), was validated, targeting just the
538 bp Schistosoma DNA amplicon. The SIX PCR was developed to obtain more targeted schistosome
species data amplicon sequence analysis, of positive samples, following an initial high-throughput
screening of snail populations with the multiplex PCR, which incorporates the internal snail control.
4.5. Sensitivity Testing
The analytical sensitivity and LoD for Schistosoma DNA in the MIX PCR were performed using
serial dilutions of S. haematobium and S. bovis gDNA. The S. haematobium and S. bovis gDNA, normalized
to 2 ng/µL (± 0.05 ng/µL), was diluted using nuclease-free water by one in ten (0.2 ng/µL), one in one
hundred (0.02 ng/µL), and one in one thousand (0.002 ng/µL). 1 µL of each Schistosoma gDNA dilution
was used in each multiplex PCR together with 1 µL of the B. wrighti gDNA (31.3 ng/µL).
Sensitivity was tested using controlled laboratory snail infections. Infections were performed
by the Schistosomiasis Resource Center (SRC) (Biomedical Research Institute, Maryland, USA [62])
using their B. truncatus/S. haematobium (Egyptian strain) model lifecycle system. Juvenile B. truncatus
(2–3 mm, n = 133) was divided into three groups, with individual snails in each group being
exposed to either 1, 2, or several (~7) S. haematobium miracidia, respectively (Table 3). Miracidia,
hatched in freshwater from eggs collected from S. haematobium-infected male LVG Syrian golden
hamsters (see Ethical Statement), were added to individual wells of 24-well ELISA plates containing
the B. truncatus snails. A fine-tipped Pasteur pipette was used under a dissection microscope to
capture and deliver either an individual miracidium (for 1 and 2 miracidia exposures) or several
(~7) miracidia at a time, following the standard operating procedures (SOPs) conducted at SRC (see:
https://www.afbr-bri.org/schistosomiasis/standard-operating-procedures/).
The snails were kept in their individual wells until no miracidia were observed swimming under
a binocular microscope, assumed to have penetrated the snail (~2 h). Following 24 h after initial
exposure to the miracidia, half of each infection group was preserved in 100% ethanol for molecular
analysis. The remaining exposed B. truncatus were maintained in their separate infection groups for 11
weeks to allow the infections to mature, and since this was the first opportunity to conduct sampling
of the infected snails. Snails were maintained according to the SRC’s SOP’s (see above). Snails that
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died were recorded and promptly removed from the group. At 11 weeks post-exposure, the remaining
snails were individually induced to shed cercariae by exposure to freshwater and light. Once it had
been determined if the snails were infected and patent, they were washed, to remove any cercariae,
and preserved in 100% ethanol for molecular analysis.
Table 3. Groups of Bulinus truncatus (B.t.) experimentally challenged with either 1, 2, or ~7 S. haematobium
(S.h.) miracidia and preserved 24 h post-exposure or checked for patent S.h. infections and preserved
11 weeks (wks) post-exposure.
Infection Group No. of B.t.Exposed
No. of S.h.
Miracidia Used
No. of B.t.
Preserved at 24 h
No. of B.t. Checked for Patency at 11 wks
and Preserved (no. Shedding + ve)
1 45 1 22 22 1 (0)
2 43 2 21 19 1 (2)
3 45 ~7 23 21 1 (7)
1 One B. truncatus died from each infection group during the 11 weeks post miracidia exposure.
The MIX PCR was performed using gDNA (1 µL) extracted from six individual B. truncatus from
each group, which were preserved after 24 h—two non-patent snails from group 1 and 2, and one
non-patent snail from group 3 (11 weeks post-exposure), and one patent (shedding) snail from group 2
(11 weeks post-exposure) (Table 3). The secondary SIX PCR was performed on selected Schistosoma
positive samples, to amplify the 538 bp S. haematobium-specific amplicon for sequence analysis to
confirm that the MIX PCR was not a false-positive.
4.6. Specificity Testing and Validation on Field Samples
As part of a longitudinal xenomonitoring project on Pemba in relation to urogenital schistosomiasis
transmission [6], the ‘wild-caught’ B. globosus and B. nasutus field isolates were available for further
validation of the MIX assay. Individual snails had been collected during malacological surveys,
individually checked for patent trematode infections by cercarial shedding, and then preserved in 100%
ethanol for molecular analysis [6]. Cercariae from infected B. globosus were preserved on Whatman
FTA cards and identified using molecular methods as S. haematobium or S. bovis from two and five
snails, respectively [6]. In addition, individual B. globosus and B. nasutus (also collected from Pemba),
which were shedding two other trematode species, Euclinostomum sp. and Echinostoma sp., respectively
(unpublished data), were tested to investigate assay specificity. Additionally, 94 B. globosus snails from
Wambaa (Pemba) collected during November 2018, which were not shedding any trematode cercariae,
were tested for infections by PCR.
All samples, which gave the 538 bp Schistosoma-specific amplicon (Figure 7), were further subjected
to the SIX PCR assay with the resulting amplicons purified and sequenced to confirm the species of the
infection. The identity of the S. haematobium and S. bovis species was confirmed by analysis of the four
species’ SNPs that exist in the ITS2 region [7] between S. haematobium and S. bovis (Table 1).
4.7. Testing the Schistosoma cox1 Rapid-Diagnostic PCR (RD-PCR) for Secondary Species Identification
The patent B. globosus snails collected from Pemba shedding either S. haematobium (n = 2) or
S. bovis (n = 5) (see [6]), as detailed above, were further tested using the published multiplex RD-PCR
(see [27,33]) with an aim to provide a secondary species-specific screening method, as described in
Schols et al. (2019) [27]. This multiplex RD-PCR, capable of differentiating S. bovis and S. haematobium by
species-specific amplicon size (S. haematobium (543 bp), S. bovis (306 bp)), was performed following the
published protocol and cycling conditions described by Webster et al. (2010) [33]. Different amount of
gDNA (1 µL, 2 µL, and 3 µL) and PCR annealing temperatures (58 ◦C, 62 ◦C, and 65 ◦C) were trialed to
investigate sensitivity and specificity. The amplicons were purified, and Sanger sequenced, as described
above, using the species-specific reverse primers to confirm species/amplicon identification.
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4.8. Ethical Statement
Schistosoma haematobium experimental infections were conducted at the Biomedical Research
Institute – Schistosomiasis Resource Center (Rockville, MA, USA) animal facility maintained with
AAALAC full accreditation (Site # 000779), operating under the National Institutes of Health’s Office
of Laboratory Animal Welfare (OLAW) # A3080-01. S. haematobium parasite material was collected
from male LVG Syrian golden hamsters following percutaneous exposure to cercariae. Hamster’s
use was approved by the Institutional Animal Care and Use Committee (IACUC) of the Biomedical
Research Institute for the Animal Use Protocol, #18-01.
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